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The chemokine CXCL12 promotes T lymphocyte adhesion mediated by the integrin 41. CXCL12 activates the GTPase
Rac, as well as Vav1, a guanine-nucleotide exchange factor for Rac, concomitant with up-regulation of 41-dependent
adhesion. Inhibition of CXCL12-promoted Rac and Vav1 activation by transfection of dominant negative Rac or Vav1
forms, or by transfection of their siRNA, remarkably impaired the increase in T lymphocyte attachment to 41 ligands
in response to this chemokine. Importantly, inhibition of Vav1 expression by RNA interference resulted in a blockade of
Rac activation in response to CXCL12. Adhesions in flow chambers and soluble binding assays using these transfectants
indicated that initial ligand binding and adhesion strengthening mediated by 41 were dependent on Vav1 and Rac
activation by CXCL12. Finally, CXCL12-promoted T-cell transendothelial migration involving 41-mediated adhesion
was notably inhibited by expression of dominant negative Vav1 and Rac. These results indicate that activation of
Vav1-Rac signaling pathway by CXCL12 represents an important inside-out event controlling efficient up-regulation of
41-dependent T lymphocyte adhesion.
INTRODUCTION
Extravasation of T lymphocytes into tissues depends on
their integrin-mediated interactions with the endothelium to
achieve firm adhesion and allow resistance to detachment
from blood shear stress. The integrin 41 is a main player
in lymphocyte transendothelial migration by mediating ad-
hesion to its ligands VCAM-1 and fibronectin that are ex-
pressed by endothelial cells (Springer, 1994; Butcher and
Picker, 1996; Ebnet et al., 1996; von Andrian and Mackay,
2000). Although it can support lymphocyte arrest on high-
density VCAM-1, adhesion dependent on 41 is highly
regulated by the activity of chemokines, which bind to their
G protein-coupled receptors and rapidly promote increased
lymphocyte attachment mediated by this integrin (Springer,
1994; Butcher and Picker, 1996; von Andrian and Mackay,
2000; Rose et al., 2002). Previous reports clearly established
that interaction of the chemokine CXCL12 (SDF-1) with its
receptor CXCR4 triggers rapid up-regulation of 41-de-
pendent lymphocyte adhesion without altering 41 cell
surface expression (Grabovsky et al., 2000). Therefore, sig-
naling initiated upon CXCL12/CXCR4 interaction should
finally impinge on 41, triggering its activation.
Associated to the development of firm adhesion, lympho-
cytes adapt their morphology to a migratory phenotype that
is promoted by reorganization of their actin cytoskeleton
(Sanchez-Madrid and del Pozo, 1999; Worthylake and Burr-
idge, 2001). Key players in the regulation of the dynamics of
actin cytoskeleton are the small GTPases of the Rho subfam-
ily, such as Rho, Rac, and Cdc42 proteins, which cycle be-
tween inactive GDP-bound and active GTP-bound forms
(Etienne-Manneville and Hall, 2002; Burridge and Wenner-
berg, 2004). Guanine-nucleotide exchange factors (GEF)
stimulate the exchange of GDP for GTP to generate active
Rho GTPases that can interact with downstream targets to
produce different biological responses, whereas GTPase ac-
tivating proteins accelerate the intrinsic GTPase activity of
Rho GTPases resulting in their inactivation (Schmidt and
Hall, 2002). Activation of Rho regulates the assembly of actin
filaments, whereas Rac and Cdc42 regulate actin polymer-
ization to generate lamellipodia and filopodia protrusions,
respectively (Etienne-Manneville and Hall, 2002). Although
Rac1 is widespread expressed, Rac2 expression is restricted
to cells of the hematopoietic lineage (Burridge and Wenner-
berg, 2004)
Vav1 is a 95-kDa protein mainly expressed on hematopoi-
etic cells that functions as a GEF predominantly for Rac
(Bustelo, 2000; Turner and Billadeau, 2002; Tybulewicz et al.,
2003). Importantly, T-cells from vav1/ mice have de-
creased Rac activation (Reynolds et al., 2002), and it was
demonstrated that constitutively active Rac rescues devel-
opmental defects in vav1/ pre-T-cells (Gomez et al., 2000).
Vav proteins contain distinct domains including CH (calpo-
nin-homology), Ac (acidic), DH (Dbl-homology), PH (pleck-
strin-homology), ZF (zinc-finger), PR (proline-rich), SH3
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(Src-homology 3), and SH2 (Src-homology 2), which have
the potential to participate in different interactions (Bustelo,
2000; Turner and Billadeau, 2002). Activation of Vav GEF
activity requires phosphorylation at tyrosine residues lo-
cated in the Ac domain (Crespo et al., 1997; Aghazadeh et al.,
2000). The DH domain binds to Rho GTPases and is the
responsible for GEF activity, whereas deletion of domains
CH and Ac generates an active Vav displaying constitutive
GEF activity for Rac (Schuebel et al., 1998; Aghazadeh et al.,
2000; Bustelo, 2000). On the other hand, the SH2 and SH3
domains interact with autophosphorylated tyrosine kinases
and with several adaptor proteins (Bustelo, 2000; Turner and
Billadeau, 2002; Tybulewicz et al., 2003). Hematopoietic cells
from vav1/, as well as from rac/ knockout mice display
deficient adhesive properties, evidencing their important
roles in this process (Yang et al., 2001; Krawczyk et al., 2002;
Gu et al., 2003; Gakidis et al., 2004).
CXCL12 rapidly activates Rho GTPases and triggers actin
polymerization in lymphocytes (Nishita et al., 2002; Wright
et al., 2002). This activation takes place concomitant with the
rapid enhancement in 4 integrin-dependent adhesion in
response to this chemokine, raising the possibility that acti-
vation of Rho GTPases by CXCL12 could be functionally
associated with efficient increased adhesion.
Characterization of the role that CXCL12-promoted Rho
GTPase activation has on the regulation of integrin 41-
dependent lymphocyte adhesion is of key importance for a
better knowledge of mechanisms governing integrin acti-
vation during T lymphocyte transendothelial migration.
In the present study we have expressed mutant forms of
Rac and Vav1, as well as knocked-down their expression
by transfecting siRNA, to study their involvement on
CXCL12-promoted 41-dependent lymphocyte adhesion
and migration.
MATERIALS AND METHODS
Cells and Antibodies
The human T-cell lines Peer and Molt-4 were cultured in RPMI 1640 medium
(Life Technologies Invitrogen, Paisley, Scotland) supplemented with 10% fetal
bovine serum (FBS; Biowhittaker, Verviers, Belgium; growth medium). Hu-
man peripheral blood mononuclear cells were prepared from buffy coats
using a ficoll density gradient. T lymphocytes were isolated by negative
selection using anti-CD14– and anti-CD19–conjugated beads (Dynal ASA,
Oslo, Norway) and purity was 95% for each sample as analyzed by flow
cytometry (Coulter Epics XL, Hialeah, FL) using anti-CD3 T3b monoclonal
antibody (mAb). Human umbilical vein endothelial cells (HUVEC) were
obtained and cultured as described (Bartolome et al., 2003). Anti-CXCR4 mAb
was purchased from R&D Systems (Minneapolis, MN), anti-Rho and anti-
phosphotyrosine PY20 antibodies were from Santa Cruz Biotechnology (Santa
Cruz, CA), anti-Rac and anti-Cdc42 from BD Biosciences PharMingen (San
Diego, CA), and anti-GFP from Molecular Probes (Eugene, OR). Control mAb
P3X63 and function-blocking integrin anti-4 HP1/2 were gifts from Dr.
Francisco Sa´nchez-Madrid (Hospital de la Princesa, Madrid, Spain), whereas
nonblocking B-5G10 was from Dr. Martin E. Hemler (Dana-Farber Cancer
Institute, Boston, MA). Anti-Vav mAb was from Santa Cruz Biotechnology,
whereas polyclonal anti-DH and anti-SH2 Vav1 antibodies were generated
and described in a previous work (Zugaza et al., 2002). The anti-47 Act-1
mAb was a gift from Millenium Pharmaceuticals (Cambridge, MA).
Transfections
Peer and Molt-4 cells were transiently transfected with expression vectors
(pEGFP-C1) coding for GFP alone, GFP-fused wild-type Rac and Cdc42, or
their dominant negative counterparts (N17-Rac and N17-Cdc42). For Vav1,
we used GFP-fused Vav1 wild-type, and the mutant forms Vav1 SH3-SH2-
SH3 and CHAc (Lopez-Lago et al., 2000). Expression vectors (2 g per
million of cells) were incubated for 5 min at 4°C with cells in RPMI 1640
medium and mixtures in electroporation cuvettes (Bio-Rad, Hercules, CA)
single-pulsed at 230 V and 960 F. Cuvettes were left in ice for 10 min, and
subsequently cells were cultured in growth medium for 16 h and finally
analyzed by flow cytometry to determine GFP-expression. For nucleofection,
human T lymphocytes were washed with phosphate-buffered saline (PBS)/
EDTA 0.3 mM and resuspended in T-cell Nucleofector solution at 5  106
cells/100 l. Plasmids (5 g) were mixed with cellular suspensions and
nucleofected using an Amaxa Nucleofector device (Amaxa, Cologne, Ger-
many). After transfection, cells were transferred to growth medium, cultured
for 6 h, and analyzed by flow cytometry to determine GFP-expression. siRNA
duplexes were transfected using nucleofection protocols (Amaxa) and trans-
fectants assayed 16 h posttransfection (T-cell lines) or 6 h (T lymphocytes).
Transfection of wild-type and mutant GTPases or Vav1, or transfection of
their siRNA, did not affect cell viability as assessed in cell cycle analyses by
flow cytometry and by trypan blue exclusion (unpublished data).
Static Cell Adhesion Assays
Soluble recombinant human VCAM-1 (sVCAM-1) consisting of domains 1–4
fused to the Fc portion of IgG1 (Munoz et al., 1996), and the recombinant
FN-H89 fragment of fibronectin, which contains the CS-1 site (Mould et al.,
1994), were coated on 96-well plates (High binding, Costar, Cambridge, MA).
Before addition to wells, nontransfected cells or siRNA transfectants were
labeled with 2,7-bis(carboxyethyl)-5(6)-carboxyfluorescein-acetoxymethyl
ester (BCECF-AM; Molecular Probes, Leiden, The Netherlands). Cells were
resuspended in adhesion medium (RPMI 1640/bovine serum albumin 0.5%)
and added to wells (7.5  104 in 100 l) containing either sVCAM-1 or
FN-H89 alone or coinmobilized with CXCL12 (R&D Systems). After a 15-s
spin, plates were incubated for 2 min at 37°C, and subsequently nonbound
cells were removed by washing with RPMI 1640 medium. Adhered cells were
lysed and extent of adhesion was quantified using a fluorescence analyzer
(BMG Labtechnologies, Offenburg, Germany). For GFP transfectants, after the
2-min adhesion step and washes, bound cells were detached, counted, and
analyzed by flow cytometry to determine GFP expression. The inhibitor
AG490 (Calbiochem, Darmstadt, Germany) was used at concentrations that
were not cytotoxic, as measured in cell cycle analysis (unpublished data). To
detect Vav1 phosphorylation after cell attachment to 41 ligands, Molt-4
cells (2  107) were placed in wells containing FN-H89, sVCAM-1 or bovine
serum albumin (BSA; Medium), and plates were centrifuged for 15 s followed
by incubation for 2 min at 37°C. Cells attached to FN-H89 or sVCAM-1, or the
same cell number from wells with BSA, were solubilized and lysates subjected
to immunoprecipitation and Western blotting using anti-Vav1 antibodies.
Flow Chamber Adhesion Assays
We followed the procedure already described (Stein et al., 2003). Briefly, a 15
l-drop in PBS containing sVCAM-1 (2 g/ml) and 0.5 g of CXCL12 was
spotted on Petri dishes, which were later incorporated as lower walls of a
parallel flow chamber. Wild-type Rac or Vav1 Molt-4 transfectants were first
infused at 1 ml/min before flow rate was adjusted to 1 dyn/cm2 and observed
with a 10 objective. Events were recorded for 3–4 min for subsequent
off-line analysis. Adherent cells were washed off and DN Rac or Vav1 trans-
fectants were subsequently infused and filmed in the same field. Both wt and
DN Rac and Vav1 were infused in an alternating order to control for an
eventual washout effect of CXCL12 caused by prolonged perfusion during the
experiment. Rolling cells that became firmly adherent (stationary for at least
20 s) were expressed as sticking cells (percent of rollers becoming adherent
related to total number of interacting cells during 2-min analysis). Otherwise
interacting cells that did not firmly attach were expressed as rolling cells
(percent of rollers related to total number of interacting cells). To evaluate
shear resistance, cells were allowed to adhere for 8 min and then flow was
increased at 1 dyn/cm2 every 30 s. The number of cells remaining bound was
determined as percent of total adhered cells after 8-min adhesion stage.
Soluble Binding Assays
We followed the method described (Chan et al., 2001) with some modifica-
tions. Molt-4 cells suspended in 50 l of binding buffer (Hanks’ balanced salt
solution containing 2% FBS) at 6  106 cells/ml were preincubated at 37°C in
the presence or absence of antibodies (10 g/ml). For binding assays involv-
ing chemokine stimulation, cells were incubated for 45 s at 37°C with CXCL12
(150 ng/ml) or binding buffer alone, and then sVCAM-1/Fc at saturating
concentrations (20 g/ml) was added and incubated with cells for 75 s at
37°C. For assays involving exposure to Mn2, after preincubation with anti-
bodies cells were incubated directly with sVCAM-1/Fc in binding buffer
supplemented with 1 mM MnCl2. Binding was stopped by washing with
ice-cold binding buffer (with 0.5 mM MnCl2 for samples exposed to Mn2)
and bound sVCAM-1/Fc was detected by flow cytometry using phyco-
erythrin-conjugated AffiniPure F(ab)2 fragment goat anti-human IgG, Fc-
gamma fragment specific (Jackson ImmunoResearch Laboratories, West
Grove, PA).
RNA Interference and RT-PCR
We designed a siRNA duplex corresponding to a common sequence for
human Rac1 and Rac2 (Rac1/Rac2; targeted to bases 382–402 on rac1 gene
sequence), sense strand: ACUGAAGGAGAAGAAGCUGdTdT. siRNA du-
plexes specific for Rac1 were designed according to the sequences described
(Deroanne et al., 2003, 2005; Rac1.1, bases 229–249; Rac1.3, bases 305–325). We
also designed an siRNA for Rac1 (Rac1.M) containing a point mutation in
position 242 of Rac1.1 sequence (U to A). Four siRNA duplexes were designed
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corresponding to human Vav1 (Vav1.1, bases 1393–1413; Vav1.2, bases 307–
327; Vav1.3, bases 2134–2154; Vav1.4, bases 2512–2532 from gene sequence).
Sense strands were as follows: GAAGUGGAGCCACAUGUUCdTdT for
Vav1.1; GGAUUUUGGCAAGGUCAUCdTdT for Vav1.2; CGUCGAGGU-
CAAGCACAUUdTdT for Vav1.3; and GGAAGAUUAUUCUGAAUACdTdT
for Vav1.4. We designed a siRNA for Vav1 (Vav1.M) containing a point
mutation in position 2145 of Vav1.3 sequence (U to A). The siRNA sequence
sense strand used as negative control for siRNA activity was AUUGUAUGC-
GAUCGCAGACdTdT. Control, Rac and Vav1 siRNA duplexes were pur-
chased from Dharmacon (Lafayette, CO) and Ambion (Austin, TX). All 21-
nucleotide siRNA duplexes were verified to be specific for their targets by
Blast search against the human genome. siRNA transfectants were lysed in
TriReagent (Sigma-Aldrich, St. Louis, MO), and RNA was extracted and
reverse transcribed using M-MLV reverse transcriptase (Promega, Madison,
WI). Amplification of Vav1 was performed by PCR using primers 5-TGC-
CTATGCAGCGAGTTCTC-3 and 5-CCCTGCGATGTAGTTTGTCC-3, and
TaqDNA polymerase (Invitrogen). The PCR profile consisted of 1-min initial
denaturation at 94°C followed by 35 cycles of 30-s denaturation at 94°C, 30-s
annealing at 58°C, and 1-min and 30-s polymerization at 72°C, and finally by
10-min extension at 72°C. Aliquots of each sample were amplified using the
same conditions with human GAPDH primers 5-GGCTGAGAACGG-
GAAGCTTGTCA-3 and 5-CGGCCATCACGCCACAGTTTC-3 as cDNA
loading control.
Confocal Microscopy
Cells attached to poly-l-lysine were incubated for 5 min at 37°C with CXCL12
(150 ng/ml) or adhesion medium alone, fixed with paraformaldehyde 4% in
PBS, and mounted with mowiol. Images were captured using a Leica TCS-
SP2-AOBS-UV confocal microscope (Mannheim, Germany) with 100 oil
immersion objective. For staining of F-actin, after adhesion cells were fixed as
above and permeabilized with 0.5% Triton-X in PBS. Cells were subsequently
incubated with Alexa 633-Phalloidin (Molecular Probes) and observed with
the confocal microscope. Images displayed were captured at the same section
in the different samples.
Transendothelial Migration Assays
HUVEC (7.5  104) were plated on FN-coated upper chambers of 5-m-pore-
size Transwells (Costar), and confluent monolayers were incubated for 12 h
before the assay with TNF- (R&D Systems, Abingdon, United Kingdom) to
induce cell surface VCAM-1 expression. The lower chambers contained 600 l
of adhesion medium alone or with CXCL12 (100 ng/ml). Transfectants (3 
105) in adhesion medium were added to Transwells in the presence or absence
of antibodies (10 g/ml), followed by incubation for 3.5 h at 37°C. Extent of
transfectant migration was analyzed in a flow cytometer by passing each
sample in the same predetermined time and flow conditions. After migration,
HUVECs were stained with violet crystal to exclude any alteration in the
integrity of the monolayer.
Immunoprecipitation, Western Blotting, and GTPase
Assays
For immunoprecipitation, Molt-4 cells (1.5  107) preincubated with or with-
out CXCL12 were washed in ice-cold stop buffer and lysed as described
(Ticchioni et al., 2002). Lysates were precleared with protein A-Sepharose
(Amersham Pharmacia Biotech, Uppsala, Sweden), and supernatants were
incubated with antibodies, followed by specific coupling to protein A-Sepha-
rose beads. Proteins were eluted in Laemmli buffer, resolved by SDS-PAGE,
and transferred to polyvinylidene fluoride (PVDF) membranes (Amersham
Pharmacia Biotech). Membranes were incubated with antibodies, followed by
washing and incubation with horseradish peroxidase–conjugated secondary
antibodies. Proteins were visualized using SuperSignal chemiluminescent
substrate (Pierce, Rockford, IL). After stripping and blocking, the blots were
reprobed with control antibodies to test for total protein content or with
anti-GFP antibodies. For GTPase assays we followed essentially the method
described (Bartolome et al., 2003). Briefly, cells were exposed to CXCL12 (150
ng/ml) followed by washing with ice-cold PBS and lysis. Aliquots of extracts
were kept aside for total lysate controls, and the remaining volume was mixed
with GST-PAK-CD fusion protein (Sander et al., 1998) in the presence of
glutathione-agarose beads. The mixtures were incubated at 4°C and bound
proteins eluted in electrophoresis buffer. Proteins were separated by SDS-
PAGE and transferred to PVDF membranes that were incubated with anti-
bodies against Rac or Cdc42. Protein detection was performed as above.
Statistical Analyses
Data were analyzed by one-way analysis of variance (ANOVA), followed by
Tukey-Kramer multiple comparisons. In both analyses, the minimum accept-
able level of significance was p  0.05.
RESULTS
Inhibition of CXCL12-promoted Up-regulation of Integrin
41–dependent T-cell Adhesion by Dominant Negative
Rac or siRNA for Rac
GTPase assays performed with lysates from nonstimulated
Peer T-cells displayed minimal Rac and Cdc42 activation
(Figure 1A). Incubation with CXCL12 in solution rapidly
(1 min) promoted the activation of both GTPases in these
cells, as well as in Molt-4 T-cells (unpublished data; see also
Figure 3B), and this activation persisted up to 15 min incu-
bation. Furthermore, short-term adhesion assays (2 min at
37°C after a short spin) revealed that CXCL12 triggered an
increase in cell attachment to sVCAM-1 and FN-H89, both
when the chemokine was coimmobilized with ligands or
used in solution (Supplementary Figure 1), whereas anti-4
mAb inhibited these adhesions (unpublished data). Flow
cytometry analyses revealed that these cells did not express
the 47 integrin (unpublished data), indicating that up-
regulation of cell attachment was mediated by 41.
To investigate the potential involvement of CXCL12-pro-
moted GTPase activation on the increase of T-cell adhesion
mediated by 41, we used two different approaches. First,
we transfected Peer and Molt-4 cells with GFP-fused wild-
type (wt) or dominant negative (DN) forms of Rac or Cdc42,
as well as GFP alone (mock), and measured transfectant
attachment to 41 ligands in response to CXCL12. Domi-
nant negative GTPases compete with wt counterparts for
binding to GEFs and are unable to activate GTPase down-
stream effectors, translating into inhibition in the activation
of the endogenous GTPase pool (Feig, 1999). Western blot
analyses revealed that GFP-fused wt and DN Rac and Cdc42
were overexpressed in Molt-4 cells compared with endoge-
nous Rac and Cdc42 (Figure 1B, right). Control experiments
indicated that 41 and CXCR4 expression was unaltered
upon expression of DN Rac compared with wt Rac transfec-
tants (Supplementary Figure 2A). Cell adhesions were per-
formed as indicated above, and extent of transfectant attach-
ment was measured by flow cytometry. Overexpression of
GFP-fused wt Rac or Cdc42 did not significantly alter the
enhancement by CXCL12 of 41-mediated transfectant ad-
hesion in comparison to GFP mock transfectants, and ex-
pression of DN forms of these GTPases did not affect adhe-
sion of nonstimulated transfectants (Figure 1B, left). In
contrast, up-regulation by CXCL12 of 41-dependent at-
tachment of DN Rac transfectants was substantially re-
duced, whereas DN Cdc42 transfectants did not display
alterations in their increased adhesion (Figure 1B, left).
To investigate Rac localization on CXCL12-stimulated T-
cells, we performed confocal microscopy on Molt-4 cells
transfected with wt Rac-GFP or on mock transfectants. Im-
ages showed that CXCL12 induced in most cells a rapid
translocation of wt Rac-GFP from a diffuse cytosolic staining
in nonstimulated cells to a predominant pattern of plasma
membrane localization that was not observed in mock trans-
fectants (Figure 1C). Membrane localization of Rac-GFP
upon exposure to CXCL12 is consistent with proper cell
trafficking of active Rac-GTP (del Pozo et al., 2000).
Second, to more directly determine Rac involvement in
CXCL12-promoted enhancement of cell adhesion mediated
by 41, we transfected Molt-4 cells with two siRNA cov-
ering different Rac1 sequences (siRNA Rac1.1 and Rac1.3), as
well as with an additional siRNA recognizing a common
sequence on both Rac1 and Rac2 (siRNA Rac1/Rac2). West-
ern blotting on Rac siRNA transfectant lysates revealed a
dramatic decrease in Rac1 and Rac1/2, whereas Rac expres-
sion levels similar to those found in nontransfected cells
Vav and Rac in CXCL12-induced Adhesion Mediated by 41
Vol. 16, July 2005 3225
were detected using control siRNA (Figure 1D, top). Fur-
thermore, transfection of a siRNA differing from the siRNA
Rac1.1 sequence just in a single-base mutation (siRNA
Rac1.M) resulted in expression of normal Rac levels. In
addition, expression of another small GTP-ase, Rho, was
unaltered by transfection of siRNA for Rac. Control experi-
ments indicated that 41 and CXCR4 expression was un-
affected by transfection of Rac siRNA (Supplementary Fig-
ure 2B). Decreased Rac expression in Rac1.1, Rac1.3, and
Rac1/Rac2 siRNA transfectants correlated with a remark-
able impairment in their up-regulation of attachment to
sVCAM-1 in response to CXCL12, as compared with en-
hancement in adhesion exhibited by control or Rac1.M
siRNA transfectants (Figure 1D, bottom), thus confirming
the adhesion results obtained with DN Rac transfectants.
These data also suggest that inhibition of Rac1 expression
alone is sufficient to impair CXCL12-triggered, 41-depen-
dent adhesion.
Role of Vav1 on CXCL12-promoted Up-regulation in
41-mediated T-cell Adhesion
Phosphorylated Vav1 catalyzes GDP release from Rac and
transition to a GTP-bound active form. CXCL12 rapidly (1
min) and transiently activated Vav1 on Molt-4 cells, as de-
tected by its increase in tyrosine phosphorylation (5–10-fold
at 1 min; Figure 2A). To investigate the role of Vav1 activa-
tion by CXCL12 on 41-dependent adhesion, we compared
the attachment to sVCAM-1 of Molt-4 transfectants express-
ing GFP-fused mutant and wt Vav1. For mutant Vav1 we
used a truncated form that only contains the C-terminal
SH3-SH2-SH3 region (Vav 1 SH3-SH2-SH3; Figure 2B, top;
Zugaza et al., 2002), a domain that interacts with tyrosine
kinases responsible for Vav1 phosphorylation. Thus, this
mutant should interfere with the activation of endogenous
Vav1 by sequestering kinases important for its phosphory-
lation, therefore acting as a putative dominant negative. In
addition, we used a mutant Vav1 lacking the CH and acidic
Figure 1. Role of Rac on CXCL12-promoted 41-dependent T-cell adhesion. (A) Peer T-cells were incubated for the indicated times with
or without CXCL12, followed by cell solubilization and incubation of extracts with glutathione-agarose–bound GST-PAK-CD to detect active
Rac and Cdc42. Bound Rac and Cdc42 were determined by Western blot using anti-Rac or anti-Cdc42 mAb. Aliquots from each lysate were
kept aside for detecting total protein. (B, left) Peer or Molt-4 cells transfected with expression vectors coding for wild-type (wt) or dominant
negative (DN) Rac- or Cdc42-GFP-fusion proteins, or GFP alone (Mock), were subjected to adhesions for 2 min at 37°C to sVCAM-1 or
FN-H89 coimmobilized with or without (Medium) CXCL12. Nonbound cells were washed and extent of adhesion quantified in a flow
cytometer as specified in Materials and Methods. Percentage data of adhered GFP transfectants represent the mean  SD of at least three
independent experiments done for each panel. Right: Molt-4 transfectants were subjected to immunoblotting using the indicated antibodies.
(C) Wild-type Rac-GFP or mock Molt-4 transfectants attached to poly-Lys were incubated with or without CXCL12 and analyzed by confocal
microscopy. Equivalent cell sections corresponding to representative fields are showed. (D, top) Molt-4 cells were transfected with control
or the indicated Rac siRNA, and after solubilization, lysates were analyzed by Western blotting using anti-Rac or control mAb, followed by
sequential membrane reprobing with antipaxillin and anti-Rho antibodies. Also shown is Western blotting from nontransfected Molt-4 cells
(bottom). BCECF-AM–labeled siRNA transfectants were subjected to adhesion assays to sVCAM-1 coimmobilized with or without CXCL12
(2 min, 37°C). Extent of adhesion was quantified in a fluorescence analyzer, and data represent the mean  SD of triplicate samples from a
representative result of three independent experiments. Adhesions were significantly up-regulated, ***p  0.001, **p  0.01, or *p  0.05,
according to one-way ANOVA test.
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regions (Vav1 CHAc) that displays constitutive GEF ac-
tivity toward Rac (Schuebel et al., 1998). Endogenous Vav1
was easily detected by anti-DH Vav1 mAb in GFP mock
transfectants, as well as in wt and CHAc Vav1 transfec-
tants (Figure 2B, middle). However, these GFP-fused Vav1
forms were hardly detected unless we used anti-GFP anti-
bodies. Analysis of SH3-SH2-SH3 Vav1 transfectants re-
vealed that this form was overexpressed in comparison to
endogenous Vav1, as determined using anti-SH2 Vav1 an-
tibodies (Figure 2B, bottom).
Mock and wt Vav1 (Figure 2C), as well as Cdc42 trans-
fectants (unpublished data), showed similar levels of up-
regulation by CXCL12 of adhesion to sVCAM-1. Instead, the
extent of increase in 41-mediated adhesion was remark-
ably reduced on Vav1 SH3-SH2-SH3 transfectants. In sup-
port for an involvement of Vav1 activation in 41-depen-
Figure 2. Role of Vav1 on CXCL12-promoted 41-dependent T-cell adhesion. (A) Serum-starved Molt-4 cells were incubated for the indicated
times in the presence or absence of CXCL12. Cells were solubilized, and extracts were immunoprecipitated with anti-DH Vav1 or control
antibodies, followed by SDS-PAGE and immunoblotting using antiphosphotyrosine antibodies to detect active Vav1 or anti-DH Vav1 to control
for total Vav1. (B, top) Schematic representation of Vav1 mutants used in these experiments. The distribution of Vav1 structural domains together
with known assigned functions is shown. (B, middle and bottom) Molt-4 cells transfected with expression vectors coding for GFP-fused wt Vav1,
SH3-SH2-SH3 Vav1,CHAc Vav1, or GFP alone (Mock) were solubilized and extracts assayed by immunoblotting using the indicated antibodies.
(C) The same transfectants were subjected to adhesions for 2 min at 37°C to sVCAM-1 coimmobilized with or without (Medium) CXCL12.
Nonbound cells were washed and extent of adhesion quantified in a flow cytometer. Percentage data of adhered GFP transfectants represent the
mean  SD of three independent experiments. Adhesion was significantly up-regulated, ***p  0.001, according to one-way ANOVA test.
Adhesion was significantly increased, p 0.01, in comparison with adhesion values displayed by Vav1 wt transfectants incubated without CXCL12.
(D) Molt-4 cells were placed in wells containing FN-H89, sVCAM-1 or BSA (Medium) and subjected to adhesion for 2 min at 37°C. Cells attached to 41
ligands or the same cell number from BSA wells were solubilized, and lysates immunoprecipitated with anti-Vav1 or control antibodies, followed by
immunoblotting using antiphosphotyrosine antibodies to detect active Vav1. (E) Molt-4 cells were transfected with control or the indicated Vav1 siRNA,
and following solubilization, lysates were analyzed by Western blotting (left) or RT-PCR (right)using Vav1 specific reagents. Results were compared with
loading controls GAPDH and paxillin, respectively. Also shown is Western blotting from nontransfected Molt-4 cells. (F) Same transfectants (left), or cells
cotransfected with the indicated siRNA and GFP or wt Vav1-GFP expression vectors (right) were subjected to adhesion assays to sVCAM-1 (2 min, 37°C)
coimmobilized with or without CXCL12. Adhesion data represent the mean SD of triplicate samples from representative results of three independent
experiments for each panel. Adhesion was significantly up-regulated, ***p  0.001, **p  0.01, or *p  0.05, according to one-way ANOVA test.
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dent T-cell adhesion, we observed that Vav1 CHAc
transfectants displayed a modest but significant increase
(p  0.01) in attachment without CXCL12 stimulation, and
this chemokine further enhanced the adhesion, likely reflect-
ing activation of the endogenous Vav1 pool (Figure 2C).
Under the conditions used in our adhesion assays (2 min at
37°C after a short spin), 41-dependent adhesion per se did
not induce Vav1 phosphorylation, as analyzed from cells
attached to FN-H89 or sVCAM-1 in the absence of CXCL12
(Figure 2D), indicating that Vav1 phosphorylation was
mostly CXCL12-dependent.
To more directly assess the involvement of Vav1 in
CXCL12-promoted T-cell adhesion, we transfected siRNA
for Vav1 in Molt-4 cells and measured transfectant attach-
ment to sVCAM-1 coimmobilized with or without CXCL12.
Transfection of two siRNA (Vav1.3 and Vav1.4) covering
different Vav1 sequences resulted in a large inhibition of
Vav1 expression, whereas transfection of two additional
Vav1 siRNA (Vav1.1 and Vav1.2) produced a partial impair-
ment in expression, as compared with cells transfected with
control siRNA (Figure 2E). Furthermore, transfection of a
siRNA differing from the Vav1.3 siRNA sequence just in a
single-base mutation (siRNA Vav1.M) resulted in expression
of normal Vav1 levels. Flow cytometry experiments indi-
cated that 41 and CXCR4 expression was unaffected by
transfection with Vav1 siRNA (Supplementary Figure 2B).
Adhesion assays revealed that enhancement by CXCL12 of
attachment to sVCAM-1 was greatly impaired in cells trans-
fected with Vav1.3 and Vav1.4 siRNA, and to a lesser extent
in Vav1.2 transfectants, compared with the adhesion of con-
trol or Vav1.M siRNA transfectants (Figure 2F, left). Increase
by CXCL12 of attachment to sVCAM-1 was not affected in
cells transfected with Vav1.1 siRNA. These results were
further substantiated by rescuing the Vav1 siRNA inhibitory
effects on adhesion by overexpression of mouse Vav1 wt
vector. The mouse Vav1 mRNA sequence is not affected by
the human specific siRNA, because it contains four mis-
matches in the same sequence when compared with human
Vav1 mRNA. These data indicate that activation of Vav1 by
CXCL12 is an important signaling event for the up-regula-
tion of 41-mediated T-cell adhesion.
Altogether, the results point to a key role of activation of
Vav1-Rac signaling pathway by CXCL12 for an efficient
enhancement in 41-dependent T-cell adhesion. To inves-
tigate whether Rac activation by CXCL12 requires Vav1
activity, we performed GTPase assays for Rac with Molt-4
cells transfected with Vav1.3 siRNA. The data showed that
inhibition of Vav1 expression by siRNA resulted in a sub-
sequent blockade of Rac activation by CXCL12 (Figure 3A),
therefore indicating that CXCL12-promoted up-regulation
of T-cell attachment mediated by 41 depends on activa-
tion of Vav1-Rac signaling pathway by this chemokine.
Further support for an involvement of CXCL12-triggered
Vav1-Rac activation in 41-dependent cell adhesion came
from experiments using the Jak inhibitor AG490. Previous
reports established that Jak2 stimulates Vav1 (Matsuguchi et
al., 1995) and that CXCL12 activates the Jak/Stat pathway,
whereas inhibition of Jak with AG490 impaired CXCL12-
triggered cell responses (Vila-Coro et al., 1999). Treatment of
Molt-4 cells with AG490 prevented subsequent CXCL12-
induced Vav1 phosphorylation, concomitant with inhibition
of Rac activation in response to this chemokine (Figure 3B).
Moreover, up-regulation by CXCL12 of Molt-4 and PBL-T-
cell attachment to sVCAM-1 was substantially reduced by
this inhibitor (Figure 3C). These results indicate that simul-
taneous pharmacological inhibition of CXCL12-promoted
Vav1 and Rac activation impairs the increase in 41-medi-
ated T-cell adhesion, further pointing to the implication of
the signaling axis Vav1-Rac in the regulation of this adhe-
sion. In addition, these data identify Jak activation as an
early activation event controlling posterior increase in T-cell
attachment to 41 ligands, similarly to what was reported
for CCL21 (Stein et al., 2003).
Figure 3. CXCL12-promoted activation of Rac requires Vav1. Role of Vav1-Rac signaling axis in up-regulation by CXCL12 of 41-mediated
T-cell adhesion. (A) Molt-4 cells were transfected with control or Vav1.3 siRNA. Transfectants were subsequently incubated for the indicated
times with CXCL12 and subjected to GTPase assays to detect active Rac. (B) Molt-4 cells preincubated with or without AG490 (100 M) were
exposed to CXCL12 for the indicated times, and after cell solubilization, extracts were subjected to analysis of Vav1 phosphorylation (top)
as described in legend for Figure 2, or to GTPase assays to detect active Rac (bottom), as in Figure 1. (C) Molt-4 and PBL-T-cells incubated
with AG490 or RPMI medium alone (Control), were labeled with BCECF-AM and subjected to adhesions for 2 min at 37°C to sVCAM-1
coimmobilized with () or without () CXCL12. Nonbound cells were washed and extent of adhesion quantified in a fluorescence analyzer. Data
represent the mean  SD of triplicate samples from representative results of two independent experiments per each panel. Adhesion was
significantly inhibited, **p  0.01, according to one-way ANOVA test.
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Inhibition of Rac and Vav1 in PBL T-lymphocytes
Impairs Up-regulation by CXCL12 of 41-dependent
Adhesion
Peripheral blood T lymphocytes were transfected with mu-
tant forms of Rac and Vav1 and subjected to adhesions to
sVCAM-1 in response to CXCL12. The different GFP-fused
expression vectors were transfected by nucleofection, which
gave transfection efficiencies ranging from 40 to 70% (Figure
4A). As with Peer and Molt-4 cells, expression of wt Rac and
Vav1 in T lymphocytes did not significantly alter the degree
of increase in CXCL12-dependent adhesion to sVCAM-1 in
comparison to mock transfectants. In contrast, enhancement
of attachment to sVCAM-1 triggered by CXCL12 was nota-
bly reduced in DN Rac or Vav1 SH3-SH2-SH3 T lymphocyte
transfectants (Figure 4B, left). Moreover, Vav1 (CHAc)
transfectants displayed significantly higher adhesion with-
out CXCL12 stimulation, whereas CXCL12 further pro-
moted an up-regulation in this attachment (Figure 4B).
These results were further confirmed in adhesion assays to
sVCAM-1 using T lymphocytes transfected with siRNA for
Rac and Vav1, which showed a large inhibition on their
CXCL12-promoted attachment mediated by 41 in com-
parison with control siRNA transfectants (Figure 4B, right).
Therefore, data obtained with freshly isolated T lympho-
cytes support the participation of Rac and Vav1 on the
enhancement by CXCL12 of 41-mediated adhesion that
we observed on T-cell lines.
Inhibition of Rac and Vav1 Impairs CXCL12-promoted
Adhesion to sVCAM-1 under Flow Conditions
As integrins on lymphocytes become activated by chemo-
kines under shear conditions during attachment to endothe-
lium, we used a flow chamber to study adhesion of wt or
DN Rac or Vav1 transfectants to sVCAM-1 coimmobilized
with CXCL12. Wild-type Rac or Vav1 transfectants were
perfused at an initial shear rate of 1 dyn/cm2 and their
behavior analyzed for rolling, firm adhesion and later for
detachment at increasing shear rates. Preliminary experi-
ments indicated that in the absence of CXCL12, transfectants
predominantly rolled (unpublished data), whereas CXCL12
triggered a very rapid development of firm adhesion (1 s)
in a cell population higher than 70% in both wt Rac and
Vav1 transfectants (Figure 5, A and B, left), that was abol-
ished by pretreatment with pertussis toxin (unpublished
data). Instead, DN Rac and Vav1 SH3-SH2-SH3 transfectants
mainly rolled, with 15% of cells firmly sticking after some
rolling (p 0.01). The means of the actual cell numbers of
total tethering (rollingsticking) were 29 and 4 for wt and
SH3-SH2-SH3 Vav1 transfectants, respectively (per field and
unit of time analyzed), whereas for Rac wt and DN trans-
fectants these numbers were 24 and 4, respectively.
To evaluate shear resistance, after transfectants were al-
lowed to adhere, then flow was increased from 1 to 10
Figure 4. Inhibition of Rac and Vav1 in PBL
T lymphocytes impairs up-regulation of
41-dependent adhesion in response to
CXCL12. Peripheral blood T lymphocytes
were transfected by nucleofection with ex-
pression vectors coding for the indicated GFP-
fused forms of Rac, Vav1 or with GFP alone
(Mock), or with different siRNA for Rac and
Vav1. The different GFP transfectants were
analyzed by flow cytometry to determine GFP
expression levels (A). GFP transfectants or
BCECF-AM–labeled siRNA transfectants
were subjected to adhesions to sVCAM-1 co-
immobilized with or without (Medium)
CXCL12 for 2 min at 37°C (B). Nonbound cells
were washed and extent of adhesion quanti-
fied in a flow cytometer. Adhesion data rep-
resent the mean  SD of 3 independent ex-
periments. Adhesion was significantly up-
regulated, ***p 0.001, according to one-way
ANOVA test. Adhesion was significantly in-
creased, p  0.01, in comparison with ad-
hesion values displayed by Vav1 wt transfec-
tants incubated without CXCL12.
Figure 5. CXCL12-promoted adhesion to sVCAM-1 of Rac and
Vav1 transfectants under flow conditions. Wild-type or DN Rac (A),
or wild-type or SH3-SH2-SH3 Vav1 (B) Molt-4 transfectants were
perfused at 1 dyn/cm2 in a flow chamber coated with sVCAM-1
coimmobilized with CXCL12 and analyzed for rolling and firmly
adherent cells (left), or cell detachment after increasing shear rates
(right), as specified in Materials and Methods. Shown are representa-
tive results of at least three independent experiments for each panel.
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dyn/cm2, measuring cells remaining bound. Wild-type Rac
and Vav1 transfectants developed a substantial higher resis-
tance to detachment than their mutant counterparts, with
	50% of wt transfectants remaining bound at 3 dyn/cm2, a
shear rate that resulted in detachment of more than 95% of
DN Rac and Vav1 SH3-SH2-SH3 transfectants (Figure 5, A
and B, right). About 15% of wt transfectants still remained
bound at 10 dyn/cm2, whereas basically no mutant cells
were attached at higher rates than 3 dyn/cm2. These results
confirm data obtained with static adhesion assays and indi-
cate that expression of DN mutant Rac and Vav1 results in
impairment in the step of cell rolling toward development of
firm adhesion triggered by CXCL12, leading to inefficient
strengthening of adhesion.
Knocking-down Rac and Vav1 Expression Impairs
CXCL12-promoted Soluble Binding of sVCAM-1-Fc
To analyze the role of Rac and Vav1 on the initial steps of
CXCL12-triggered 41-dependent adhesion, we subjected
Molt-4 Rac and Vav1 siRNA transfectants to binding assays
to sVCAM-1-Fc in solution, therefore excluding adhesion
events subsequent to initial integrin/ligand interactions. To
set up the binding assay, we established the best conditions
using nontransfected Molt-4 cells. A short incubation (75 s,
37°C) in the presence of Mn2, a commonly used potent
positive control for affinity regulation, triggered a robust
binding of sVCAM-1-Fc that was abolished by preincuba-
tion with anti-4 mAb (Figure 6A), whereas no binding was
observed without Mn2 and sVCAM-1-Fc (unpublished
data) or when this cation was present but no soluble ligand
was added. Likewise, a 45-s cell exposure to CXCL12 fol-
lowed by the 75-s binding assay promoted sVCAM-1-Fc
binding though to a lower extent, which was fully blocked
by anti-4 mAb. Again, no binding was detected without
sVCAM-1-Fc (Figure 6A) or when no CXCL12 was added
(unpublished data). Molt-4 cells transfected with control
siRNA achieved soluble sVCAM-1-Fc binding to levels sim-
ilar to nontransfected cells, whereas Rac or Vav1 siRNA
transfectants showed a 50–60% reduction in sVCAM-1-Fc
binding in comparison to control siRNA transfectants (Fig-
ure 6B). Control binding experiments revealed that Rac,
Vav1, or control siRNA transfectants retained similar levels
of sVCAM-1-Fc binding upon exposure to Mn2. These
results suggest that triggering of 41-dependent T-cell ad-
hesion by CXCL12 depends on Rac and Vav1 activity al-
ready at the initial promotion of 41/VCAM-1 interac-
tions.
Mathematical modeling of the interaction between 41 and
bivalent VCAM-1-Fc revealed that both monovalent and biva-
lent binding may occur, resulting in 41/VCAM-1-Fc and
(41)2/VCAM-1-Fc complexes, respectively (Jakubowski et
al., 1995). However, at high ligand concentrations bivalent
binding begins to decrease because of an excess of compet-
ing monovalent binding that has low affinity and results in
overall decrease in detectable binding. Because our assays
are performed at saturating concentrations of sVCAM-1-Fc,
monovalent binding should indeed take place. We used
monomeric VCAM-1 instead of bivalent sVCAM-1-Fc in an
attempt to further characterize the binding of soluble
VCAM-1 to the different siRNA transfectants. Preliminary
control experiments indicated that VCAM-1 supported
static adhesion of Molt-4 cells that was fully blocked by
anti-4 mAb (Supplementary Figure 3A). Mn2 triggered
41-dependent binding of VCAM-1 to Molt-4 cells but to
substantially lower levels compared with sVCAM-1-Fc bind-
ing (Supplementary Figure 3B), in agreement with previous
Figure 6. Soluble binding of sVCAM-1-Fc to Molt-4 Rac or Vav1 siRNA transfectants. (A) Molt-4 cells preincubated with control (P3X63)
or anti-4 mAb, or in binding medium alone, were incubated directly with or without sVCAM-1-Fc in the presence of Mn2 (left), or with
CXCL12 before addition of sVCAM-1-Fc (right). (B) Molt-4 cells transfected with control, Rac or Vav1 siRNA, were preincubated in the
presence or absence of CXCL12, or with Mn2, followed by binding assay to sVCAM-1-Fc. Cell bound ligand was detected by PE-conjugated
goat anti-human IgG using flow cytometry. Insert numbers represent mean fluorescence intensity units.
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results on the low affinity of 41/monovalent VCAM-1
interaction (Jakubowski et al., 1995). In addition, untrans-
fected Molt-4 cells, or cells transfected with Rac, Vav1, or
control siRNA incubated with CXCL12, were unable to bind
VCAM-1, whereas binding was preserved with transfec-
tants exposed to Mn2 (Supplementary Figure 3C). There-
fore, we were unable to test whether a possible Rac-induced
41 clustering dependent on bivalent sVCAM-1-Fc could
account for a certain level of binding independent of
CXCL12-promoted Vav1-Rac activation. However, our data
together with the abovementioned observations on the char-
acterization of 41/VCAM-1-Fc interactions strongly
points to the importance of the activation of Vav1-Rac by
CXCL12 on the subsequent stimulation of 41-mediated
T-cell interaction with VCAM-1.
T-cell Morphology on CXCL12-promoted Adhesion to
41 Ligands
To obtain morphological insights into the modulation by
CXCL12 of 41-dependent adhesion, we performed confo-
cal microscopy on Molt-4 cells subjected to attachment to
FN-H89 or sVCAM-1 coimmobilized with or without
CXCL12. Cells attached to 41 ligands in the presence of
CXCL12 displayed substantially higher degree of spreading,
as indicated by enlargement of cell diameter and reduction
of thickness, than cells adhered in the absence of the che-
mokine (Figure 7A). Although spreading was clearly de-
tected on both ligands, it was generally more evident on
FN-H89, and cells attached on this ligand coimmobilized
with CXCL12 showed a polarized morphology, whereas
those adhered to sVCAM-1 displayed a predominant round
phenotype with lamelipodia protrusions. CXCL12 promoted
the spreading of wt Rac transfectants on FN-H89 and to a
lesser extent on sVCAM-1, whereas it failed to induce
spreading of DN Rac transfectants (Figure 7B), indicating
that triggering of 41-mediated T-cell adhesion results in
development of a remarkable spread phenotype that is de-
pendent on Rac activity.
Inhibition of Vav1 and Rac Impairs CXCL12-promoted
Induction of Integrin 41-dependent T-cell
Transendothelial Migration
To determine the role of Vav1 and Rac on CXCL12-triggered
T-cell migration involving 41 activity, we subjected wt
and DN Vav1, Rac, and Cdc42 Peer cell transfectants to
migration assays across confluent layers of TNF--activated
HUVEC (to induce VCAM-1 expression; unpublished data).
The results revealed that CXCL12-promoted migration of
DN Rac or Vav1 SH3-SH2-SH3 transfectants was substan-
tially lower than that displayed by transfectants expressing
wt Rac, Vav1, or Cdc42, or DN Cdc42 (Figure 8). This
migration was inhibited by anti-CXCR4 mAb (unpublished
data), and by anti-4 (Figure 8), indicating that was medi-
ated by 41. Together, these data indicate that activation of
Rac and Vav1 by CXCL12 is a key signaling event that leads
to efficient up-regulation of 41-dependent T-cell adhesion
and transendothelial migration.
DISCUSSION
CXCL12 promotes T lymphocyte adhesion involving a rapid
and transient up-regulation of the integrin 41 activity
Figure 7. Alterations in cell morphology during CXCL12-pro-
moted T-cell attachment to 41 ligands.(A) Molt-4 cells were sub-
jected to adhesions (2 min at 37°C) to FN-H89 or sVCAM-1 coim-
mobilized with or without CXCL12 on coverslips. Nonbound cells
were removed and attached cells were fixed, stained with Alexa
633-Phalloidin, and analyzed by confocal microscopy. Shown are
equivalent cell sections corresponding to representative fields. (B)
Molt-4 cells were transfected with GFP-fused wt or DN Rac forms
and subjected to adhesion assays to 41 ligands and confocal
microscopy as above. Only GFP-positive transfectants are dis-
played.
Figure 8. Expression of DN Rac or Vav1 impairs CXCL12-pro-
moted, 41-mediated, transendothelial T-cell migration. Peer cells
transfected with the indicated GFP-fused forms of Vav1, Rac, or
Cdc42, or with GFP alone (Mock), were placed on top of TNF--
treated HUVEC confluent monolayers in the presence of control
(P3X63) or anti-4 mAb, or adhesion medium alone (Medium) and
subjected to transendothelial migration assays in response to
CXCL12. Extent of cell migration was analyzed in a flow cytometer,
and data represent the mean  SD of duplicate samples from one
representative result from three independent experiments. Migra-
tion was significantly stimulated, ***p  0.001, according to one-
way ANOVA test.
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(Grabovsky et al., 2000), a dynamic process controlling lym-
phocyte migration. CXCL12 rapidly activates Rac and
Cdc42, which takes place concomitant with increase in 41-
dependent lymphocyte adhesion, as reported here. Using
Molt-4 and Peer T-cells transfected with dominant negative
Rac, or knocking-down its expression by transfection of
siRNA for Rac, we show that activation of Rac by CXCL12
represents an important signaling event for efficient en-
hancement of 41-mediated T-cell adhesion. In contrast,
DN Cdc42 transfectants displayed no alterations on their
increase in attachment to 41 ligands upon stimulation
with CXCL12.
Phosphorylation of Vav1 is a required step for the stimu-
lation of its GEF activity predominantly on Rac (Crespo et
al., 1997; Aghazadeh et al., 2000). Our data indicated that
CXCL12 rapidly phosphorylated Vav1 and that expression
of a putative DN Vav1 form that should interfere with its
phosphorylation (Vav1 SH3-SH2-SH3; Zugaza et al., 2002),
results in a notable reduction in up-regulation of 41-
dependent Molt-4 cell adhesion triggered by CXCL12. The
relevance of Vav1 activation on CXCL12-promoted increase
in attachment to 41 ligands was further substantiated by
transfection of siRNA specific for Vav1. Moreover, transfec-
tants expressing a mutant Vav1 form that displays constitu-
tive GEF activity toward Rac (Vav1 CHAc; Schuebel et
al., 1998) showed an increase in basal (no CXCL12 stimula-
tion) cell attachment to sVCAM-1, an additional indication
of the functional link between Vav1 and Rac on the up-
regulated T-cell adhesion. Importantly, inhibition of Vav1
expression by transfection of siRNA for Vav1 resulted in a
blockade of Rac activation in response to CXCL12, a result
that strongly suggests that the activation of Vav1-Rac sig-
naling axis by CXCL12 represents an important inside-out
event leading to stimulation of 41-mediated T-cell adhe-
sion. This direct key observation is supported by indirect
experimental evidence pointing to a linear Vav1-Rac signal-
ing activated by CXCL12 and leading to increased adhesion.
First, expression of DN Rac or transfection with siRNA for
Rac, although theoretically preserving Vav1 phosphoryla-
tion by CXCL12, resulted in inhibition of CXCL12-promoted
up-regulation of 41-dependent adhesion to levels similar
to those achieved by DN Vav1 transfectants or by cells
transfected with Vav1 siRNA. Second, inhibition of Jak2, a
signaling molecule activated by CXCL12 (Vila-Coro et al.,
1999) that activates Vav (Matsuguchi et al., 1995), provoked
the blockade of Vav1, as well as Rac activation, in addition
to inhibiting T-cell adhesion to 41 ligands in response to
CXCL12. More definitive support for Vav1-Rac axis comes
from the demonstration that T-cells from vav1/ mice have
substantially decreased Rac activation (Reynolds et al., 2002).
At present we cannot however completely exclude the par-
ticipation of an additional Vav1-dependent, Rac-indepen-
dent, signaling pathway modulating CXCL12-triggered in-
crease in 41-mediated T-cell adhesion. Thus, a previous
work reported GEF-dependent, as well as independent, ac-
tivity of Vav1 on T-cell spreading on fibronectin mediated
by 1 integrins (del Pozo et al., 2003).
Importantly, the functional association of Vav1 and Rac
activation with an efficient enhancement in 41-mediated
T-cell line adhesion in response to CXCL12 was also ob-
served with fresh T lymphocytes isolated from human PBL
and transfected with DN forms or siRNA for these proteins.
The possibility that alterations in cell surface expression of
41 and CXCR4 due to transfection of DN Rac or siRNA
for Rac or Vav1, or induction of cell death, that could be
responsible for cell adhesion changes mentioned above were
excluded upon flow cytometry analyses.
Dynamic regulation of adhesion is a prerequisite for effi-
cient cell migration (Ridley et al., 2003). As 41 plays key
roles during T-cell transendothelial migration, we ap-
proached this process by using migration chambers to assay
the capability of DN Rac or Vav1 transfectants to migrate
toward CXCL12 across TNF- activated HUVEC. The re-
sults indicated that triggering by CXCL12 of efficient T-cell
transendothelial migration mediated by 41 was depen-
dent on Vav1 and Rac activation. The data on cell migration
likely reflects the defects on 41-dependent adhesion to
VCAM-1 and fibronectin of DN Vav1 and Rac transfectants
in response to CXCL12 as shown above. Therefore, these
results confirm in a more complex adhesion scenario the
importance of Vav1 and Rac activation during CXCL12-
promoted, 41-mediated T-cell attachment.
Identification of adhesion events regulated by Vav1 and
Rac activation during 41-dependent attachment induced
by CXCL12 came from soluble ligand binding, adhesion in
flow chambers, and confocal microscopy experiments. 41
on cells transfected with siRNA for Vav1 or Rac displayed a
substantial, but not total, impairment in CXCL12-promoted
binding to soluble VCAM-1. The degree of inhibition of
binding was similar between Vav1 and Rac siRNA transfec-
tants, again pointing to the involvement of a Vav1-Rac sig-
naling axis activated by CXCL12 during adhesion. On the
other hand, adhesion assays under shear stress carried out
on sVCAM-1 coimmobilized with CXCL12 indicated that
activation of Vav1 and Rac was necessary to develop and
maintain T-cell firm adhesion against detachment from in-
creased shear rates. Finally, expression of DN Rac interfered
with CXCL12-promoted transfectant spreading on 41 li-
gands that otherwise was observed with wt Rac transfec-
tants, as well as with nontransfected cells. Together, these
results indicate that activation by CXCL12 of Vav1 and Rac
leads to increased binding to its ligands and that this acti-
vation is required to maintain a sufficient level of adhesion
strengthening to allow resistance of cell detachment from
shear stress. CXCL12-promoted, Rac-dependent, spread cell
phenotype could represent an important mechanism for ad-
hesion strengthening mediated by 41, as it should more
efficiently resist shear stress.
Efficient soluble binding of ligands to integrins is consid-
ered to reflect integrin high- affinity conformations (Lidding-
ton and Ginsberg, 2002; Carman and Springer, 2003). In this
regard, CXCL12-triggered binding of VCAM-1 to 41 in
solution has been proposed to be the result of high-affinity
41, a finding that was supported by increased binding on
CXCL12-treated cells of anti-1 mAb that detect high-affin-
ity 1 integrins (Chan et al., 2001). Therefore, our results
raise the possibility that activation of Vav1-Rac by CXCL12
might constitute one of the mechanisms contributing to a
switch from low to higher affinity 41 conformations that
are efficient for initial ligand binding, although failure to
detect monovalent binding does not allow at present to
conclusively demonstrate this point. In addition, the data
also suggest that Vav1-Rac activation could contribute to the
sustenance of the high-affinity state to mediate cell arrest.
However, it is important to keep in mind that Vav1 and Rac
siRNA transfectants retained a portion (45%) of CXCL12-
promoted soluble VCAM-1 binding, indicating that some
efficient binding was still achieved, as discussed below. As
impairment in Vav1 and Rac activation lead to a predomi-
nant rolling behavior on VCAM-1, these results suggest that
Vav1 and Rac activation by CXCL12 appears to be more
critical in the adhesion strengthening step. The importance
of Vav1 in sustained adhesion and spreading has been also
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recently reported for 2 integrin-dependent neutrophil ad-
hesion (Gakidis et al., 2004).
Solid evidence indicates the existence of a variety of 
integrin heterodimer conformations displaying from low to
high-affinity for their ligands. The latest is generated upon
unclasping of  cytoplasmic and transmembrane domains
leading to an extended extracellular domain from the bent,
low-affinity conformation, representing an important mech-
anism for integrin activation in inside-out signaling (Emsley
et al., 2000; Xiong et al., 2001; Liddington and Ginsberg, 2002;
Takagi et al., 2002; Vinogradova et al., 2002; Carman and
Springer, 2003; Shimaoka et al., 2003; Vinogradova et al.,
2004). Talin is an actin-binding protein that activate integrins
upon interaction with the  subunit cytoplasmic domains
(Liu et al., 2000; Tadokoro et al., 2003). Importantly, FRET
analyses showed that L2 binding to the talin head domain
or stimulation with CXCL12 caused spatial separation of the
subunit cytoplasmic domains (Kim et al., 2003), confirming
that this structural change is a key event in inside-out sig-
naling. Therefore, it is tempting to speculate that CXCL12-
promoted stimulation of Vav1 and/or Rac might induce
talin binding to the 1 subunit and activation of the 41
heterodimer resulting in stronger interaction with its li-
gands. A possible link with this hypothesis arises from the
fact that Vav1 has been reported to interact with talin (Fi-
scher et al., 1998), which opens the possibility that CXCL12
might signal via Vav1-talin. Whether part of this signaling
represents Rac-independent events deserves further investi-
gation.
Members of the Ras-family GTP-ases such as R-ras, H-ras,
and Rap1, are involved in activation of 41-dependent
adhesion of hematopoietic cells (Kinbara et al., 2003). Rap1
triggers 1- and 2-integrin dependent lymphocyte adhe-
sion, and expression of active Rap1 promotes both increased
affinity and avidity for 1- and 2-integrin ligands
(Reedquist et al., 2000; Sebzda et al., 2002; Katagiri et al.,
2004). In addition, CXCL12 and CCL21 up-regulate lympho-
cyte adhesion mediated by these integrins through Rap1
activation (Shimonaka et al., 2003; Katagiri et al., 2004).
Therefore, Rap is a serious candidate to mediate the binding
of VCAM-1 promoted by CXCL12 that is independent of
Vav1 and Rac (see above). However, functional connections
have been recently reported between Rap1 and Rac. Al-
though not yet documented in lymphocytes, Rap1 activation
by the GEF Epac leads to Rac activation (Maillet et al., 2003),
and active Rap1 induces Vav2 membrane localization and
Rac activation (Arthur et al., 2004). On the other hand, Vav1
and Rac control membrane translocation of RasGRP2, a GEF
for Rap1, translating into Rap1 activation (Caloca et al.,
2004). These data illustrate the potential cross-talks between
Vav1-Rac and Rap1 and raise the possibility that they could
contribute to the increase by CXCL12 of lymphocyte adhe-
sion mediated by 41.
Previous data showed that binding of VCAM-1-Fc pro-
moted by CXCL12 was not affected by cytochalasin D, sug-
gesting that interaction of VCAM-1 with 41 does not
require active actin polymerization (Chan et al., 2001). How-
ever, cytochalasin D did inhibit postligand binding events.
These data together with the present results suggest that
initial 41/VCAM-1 interactions promoted by CXCL12
and dependent on Vav1 and Rac activation precedes actin
polymerization and that subsequent adhesion strengthening
mediated by 41 does require reorganization of the actin
cytoskeleton. Clustering of high-affinity 41 by diffusion
mobility should increase the overall avidity for its ligands.
Therefore, if CXCL12 generates 41 high-affinity conforma-
tions as well as 41 clustering, both mechanisms could
cooperate at different steps during adhesion to mediate firm
attachment. Using the nonblocking anti-4 mAb B-5G10 in
confocal microscopy, we have been unable to detect
CXCL12-promoted changes in 41 distribution on Molt-4
cell surfaces, at least at the level of macroclusters (unpub-
lished data). This does not rule out that microclusters not
detected by confocal microscopy might form in response to
CXCL12, which could account for increased avidity for 41
ligands and contribute to the increase in adhesion. Indeed,
41 clusters have been reported in T lymphocytes trans-
fected with active Rac that lead to enhancement in 41-
dependent adhesion (D’Souza-Schorey et al., 1998).
In conclusion, this study indicates that activation of Vav1-
Rac pathway by CXCL12 constitutes an important inside-out
signaling event for efficient up-regulation of 41-depen-
dent T lymphocyte adhesion, both at initial ligand binding
and specially during adhesion strengthening by sustaining
firm attachment to mediate cell arrest. It is likely that Vav1-
Rac rapid activation by chemokines precedes subsequent,
ligand-induced activation of this signaling pathway in an
outside-in manner (Yron et al., 1999; Moores et al., 2000; del
Pozo et al., 2003). The latter could further contribute to
maintaining or even increasing the adhesion strength neces-
sary to resist cell detachment and to set lymphocytes ready
for diapedesis. Further investigation is required to identify
Vav1 and Rac upstream and downstream molecules that
collaborate to increase in adhesion in response to CXCL12.
One of the upstream events in CXCL12-stimulated signaling
is the activation of Gi-dependent pathway, as pertussis
toxin blocks up-regulation of 41-mediated T-cell attach-
ment, and therefore functional relationships should exist
between this pathway and Vav1-Rac activation by CXCL12.
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